These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 28926143)
21. A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis. Barbour S; Djurdjev O; Gill JS; Dong JJ; Gill J Kidney Int; 2019 Aug; 96(2):460-469. PubMed ID: 31248649 [TBL] [Abstract][Full Text] [Related]
22. Steroids and recurrent IgA nephropathy after kidney transplantation. Clayton P; McDonald S; Chadban S Am J Transplant; 2011 Aug; 11(8):1645-9. PubMed ID: 21797974 [TBL] [Abstract][Full Text] [Related]
23. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy? Courtney AE; McNamee PT; Nelson WE; Maxwell AP Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729 [TBL] [Abstract][Full Text] [Related]
24. Risk for graft loss in pediatric and young adult kidney transplant recipients due to recurrent IgA nephropathy. Engen RM; Bartosh SM; Smith JM; Perkins JD; Harshman LA Am J Transplant; 2024 Jan; 24(1):37-45. PubMed ID: 37595842 [TBL] [Abstract][Full Text] [Related]
25. Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. Bjørneklett R; Vikse BE; Smerud HK; Bostad L; Leivestad T; Hartmann A; Iversen BM Clin Transplant; 2011; 25(3):E356-65. PubMed ID: 21651619 [TBL] [Abstract][Full Text] [Related]
26. Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up. Khalil A; Mujtaba MA; Aljanabi OT; Ghabril MS; Taber TE; Yaqub MS; Sharfuddin A Exp Clin Transplant; 2017 Jun; 15(3):282-288. PubMed ID: 27310008 [TBL] [Abstract][Full Text] [Related]
27. Effects of acute rejection vs new-onset diabetes after transplant on transplant outcomes in pediatric kidney recipients: analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database. Mehrnia A; Le TX; Tamer TR; Bunnapradist S Pediatr Transplant; 2016 Nov; 20(7):952-957. PubMed ID: 27578397 [TBL] [Abstract][Full Text] [Related]
28. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation. Grupper A; Grupper A; Daly RC; Pereira NL; Hathcock MA; Kremers WK; Cosio FG; Edwards BS; Kushwaha SS J Heart Lung Transplant; 2017 Mar; 36(3):297-304. PubMed ID: 27642059 [TBL] [Abstract][Full Text] [Related]
29. Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation. Garnier AS; Duveau A; Demiselle J; Croué A; Subra JF; Sayegh J; Augusto JF PLoS One; 2018; 13(4):e0196101. PubMed ID: 29694420 [TBL] [Abstract][Full Text] [Related]
30. Racial disparity in kidney transplant survival relates to late rejection and is independent of steroid withdrawal. Liu A; Woodside KJ; Augustine JJ; Sarabu N Clin Transplant; 2018 Sep; 32(9):e13381. PubMed ID: 30098053 [TBL] [Abstract][Full Text] [Related]
31. Early recurrence of active IgA nephropathy after kidney transplantation. Otsuka Y; Takeda A; Horike K; Inaguma D; Goto N; Watarai Y; Morozumi K Nephrology (Carlton); 2014 Jun; 19 Suppl 3():45-8. PubMed ID: 24842823 [TBL] [Abstract][Full Text] [Related]
32. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS; Rosenstiel PE; Zaky ZS; Tsapepas DS; Appel GB; Markowitz GS; Bomback AS; Canetta PA Am J Nephrol; 2017; 45(2):99-106. PubMed ID: 28056461 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy. Sato Y; Ishida H; Shimizu T; Tanabe K Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415 [TBL] [Abstract][Full Text] [Related]
34. Recurrent IgA nephropathy in renal transplant allografts. Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693 [TBL] [Abstract][Full Text] [Related]
35. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression. Lionaki S; Makropoulos I; Panagiotellis K; Vlachopanos G; Gavalas I; Marinaki S; Liapis G; Michelakis I; Bokos I; Boletis I PLoS One; 2021; 16(8):e0253337. PubMed ID: 34403416 [TBL] [Abstract][Full Text] [Related]
36. Clinical importance of the updated Oxford classification in allograft IgA nephropathy. Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura. Samuel JP; Bell CS; Molony DA; Braun MC Clin J Am Soc Nephrol; 2011 Aug; 6(8):2034-40. PubMed ID: 21700827 [TBL] [Abstract][Full Text] [Related]
38. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT. Lemes-Canuto AP; de Sandes-Freitas TV; Medina-Pestana JO; Mastroianni-Kirsztajn G J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382 [TBL] [Abstract][Full Text] [Related]
39. Higher Incidence of Renal Allograft Glomerulonephritis in Living-Related Donor Kidney Transplantation. Deng R; Dai Y; Zhang H; Liu L; Li J; Xiong Y; Deng S; Fu Q; Wang C Transplant Proc; 2018 Oct; 50(8):2421-2425. PubMed ID: 30316370 [TBL] [Abstract][Full Text] [Related]
40. Patient characteristics and outcomes by GN subtype in ESRD. O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]